PIEPER STEVEN (Chief Financial Officer) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/2/2026ACC: 0001875714-26-000002
Officer· Chief Financial Officer
Since Oct 2021
+156.66K
Net shares
Net buyer
$1.51M
Total sold
0
Open market trades
0B · 0S
5
Total transactions
362.19K acquired · 205.53K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+154.99K
Price / share
—
Trade value
—
% of position
10.9%
1/30/2026
1.42M→1.57M
Common Stock
Direct
Shares
−111.77K
Price / share
$7.36
Trade value
$822.59K
% of position
7.1%
1/31/2026
1.57M→1.46M
Common Stock
Direct
Shares
−66.45K
Price / share
$7.36
Trade value
$489.07K
% of position
4.5%
1/31/2026
1.46M→1.39M
Common Stock
Direct
Shares
−27.32K
Price / share
$7.36
Trade value
$201.07K
% of position
2.0%
1/31/2026
1.39M→1.37M
Total
Net shares
−50.55K
Net value
-$1.51M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/30/2026 | A · Award | +154.99K | — | — | 10.9% | 1.42M | 1.57M |
| Common Stock Direct | 1/31/2026 | F · Tax Withholding | −111.77K | $7.36 | $822.59K | 7.1% | 1.57M | 1.46M |
| Common Stock Direct | 1/31/2026 | F · Tax Withholding | −66.45K | $7.36 | $489.07K | 4.5% | 1.46M | 1.39M |
| Common Stock Direct | 1/31/2026 | F · Tax Withholding | −27.32K | $7.36 | $201.07K | 2.0% | 1.39M | 1.37M |
| Total | −50.55K | -$1.51M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
207.21K shares
Shares
+207.21K
Strike price
7.36
Held after
207.21K
Exercisable
—
1/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock207.21K shares | 1/30/2026 | A · Award | +207.21K | 7.36 | — | 207.21K |